Drug Shortage Report for JAMP-ALENDRONATE
Report ID | 183760 |
Drug Identification Number | 02385031 |
Brand name | JAMP-ALENDRONATE |
Common or Proper name | Alendronate sodium trihydrate |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1x4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-02-06 |
Estimated end date | 2025-12-31 |
Actual end date | 2024-04-15 |
Shortage status | Resolved |
Updated date | 2024-04-17 |
Company comments | New DIN available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-04-17 | French | Compare |
v6 | 2024-04-17 | English | Compare |
v5 | 2024-02-19 | French | Compare |
v4 | 2024-02-19 | English | Compare |
v3 | 2023-02-07 | English | Compare |
v2 | 2023-02-06 | French | Compare |
v1 | 2023-02-06 | English | Compare |
Showing 1 to 7 of 7